Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CNY
Unlock Free Earnings Estimates
CARDIOFLOW-B: 2024 Interim Report
Sep 26 04:52 ET
CARDIOFLOW-B: ANNOUNCEMENT OF UNAUDITED INTERIM RESULTSFOR THE SIX MONTHS ENDED JUNE 30, 2024
Aug 28 10:44 ET
CARDIOFLOW-B: DATE OF BOARD MEETING
Aug 14 04:33 ET
CARDIOFLOW-B: PROFIT FORECAST FOR THE FIRST HALF OF 2024 -SIGNIFICANT REDUCTION IN NET LOSS OFAPPROXIMATELY 63% TO 72%
Jul 24 09:18 ET
Read more
Updated: Nov 29, 2024
Strong Buy
Buy
Hold
Underperform
Sell
No Data